Paper42908014PubMed
Heterogeneity in the treatment effect of sodium-glucose cotransporter-2 inhibitor on chronic kidney disease risk reduction: a prevalent new user cohort study applying double/debiased machine learning.
Kongmalai T and 8 others. Diabetol Metab Syndr, 2026.
Cite this record
ConductScience Library. Heterogeneity in the treatment effect of sodium-glucose cotransporter-2 inhibitor on chronic kidney disease risk reduction: a prevalent new user cohort study applying double/debiased machine learning. Papers, record 42908014. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42908014
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Heterogeneity in the treatment effect of sodium-glucose cotransporter-2 inhibitor on chronic kidney disease risk reduction: a prevalent new user cohort study applying double/debiased machine learning.
- Journal
- Diabetol Metab Syndr
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-10-24
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| N42A690510 | National Research Council of Thailand | PubMed |
Source PubMed
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38078590 | 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2024. | Diabetes Care | 2024 | https://conductscience.org/library/papers/38078590 | PubMed |
| 2 | 38501205 | Individualized Treatment Effects of Oxygen Targets in Mechanically Ventilated Critically Ill Adults. | JAMA | 2024 | https://conductscience.org/library/papers/38501205 | PubMed |
| 3 | 32970396 | Dapagliflozin in Patients with Chronic Kidney Disease. | N Engl J Med | 2020 | https://conductscience.org/library/papers/32970396 | PubMed |
| 4 | 36568108 | Risk factors of chronic kidney disease among type 2 diabetic patients with longer duration of diabetes. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/36568108 | PubMed |
| 5 | 8892489 | Advantages and disadvantages of using artificial neural networks versus logistic regression for predicting medical outcomes. | J Clin Epidemiol | 1996 | https://conductscience.org/library/papers/8892489 | PubMed |
| 6 | 38388753 | Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. | Diabetologia | 2024 | https://conductscience.org/library/papers/38388753 | PubMed |
| 7 | 30990260 | Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. | N Engl J Med | 2019 | https://conductscience.org/library/papers/30990260 | PubMed |
| 8 | 28089956 | Robust causal inference using directed acyclic graphs: the R package 'dagitty'. | Int J Epidemiol | 2016 | https://conductscience.org/library/papers/28089956 | PubMed |
| 9 | 18313558 | The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. | J Clin Epidemiol | 2008 | https://conductscience.org/library/papers/18313558 | PubMed |
| 10 | 37161041 | Machine learning-based causal models for predicting the response of individual patients to dexamethasone treatment as prophylactic antiemetic. | Sci Rep | 2023 | https://conductscience.org/library/papers/37161041 | PubMed |
| 11 | 28693043 | Sensitivity Analysis in Observational Research: Introducing the E-Value. | Ann Intern Med | 2017 | https://conductscience.org/library/papers/28693043 | PubMed |
| 12 | 36397062 | Effects of second-line antihyperglycemic drugs on the risk of chronic kidney disease: applying a target trial approach to a hospital-based cohort of Thai patients with type 2 diabetes. | Cardiovasc Diabetol | 2022 | https://conductscience.org/library/papers/36397062 | PubMed |
| 13 | 16731850 | Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. | Diabetes | 2006 | https://conductscience.org/library/papers/16731850 | PubMed |
| 14 | 38490803 | KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. | Kidney Int | 2024 | https://conductscience.org/library/papers/38490803 | PubMed |
| 15 | 37328784 | Comparison of causal forest and regression-based approaches to evaluate treatment effect heterogeneity: an application for type 2 diabetes precision medicine. | BMC Med Inform Decis Mak | 2023 | https://conductscience.org/library/papers/37328784 | PubMed |
| 16 | 39624210 | Associated Factors for Chronic Kidney Disease in Patients with Diabetes Mellitus 2: Retrospective Study. | Int J Nephrol Renovasc Dis | 2024 | https://conductscience.org/library/papers/39624210 | PubMed |
| 17 | 35909178 | Hierarchy of Evidence Within the Medical Literature. | Hosp Pediatr | 2022 | https://conductscience.org/library/papers/35909178 | PubMed |
| 18 | 37929568 | Delayed versus primary closure to minimize risk of surgical-site infection for complicated appendicitis: A secondary analysis of a randomized trial using counterfactual prediction modeling. | Infect Control Hosp Epidemiol | 2024 | https://conductscience.org/library/papers/37929568 | PubMed |
| 19 | 35534565 | Heterogeneity in phenotype, disease progression and drug response in type 2 diabetes. | Nat Med | 2022 | https://conductscience.org/library/papers/35534565 | PubMed |
| 20 | 36335315 | Real-world data: a brief review of the methods, applications, challenges and opportunities. | BMC Med Res Methodol | 2022 | https://conductscience.org/library/papers/36335315 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42908014
GET https://conductscience.org/api/papers/v1/42908014/references?page=2